1. US FDA is making sure that major disruptions in clinical trials are kept to a minimum. The final guidance that was issued discusses the transfer of review responsibility from one IRB to another and how it should be handled.
2. Melatonin has always been know to help with regulating sleep cycles. But now studies show melatonin supplements may reset the circadian rhythms of those who are at risk of developing osteoporosis. Helping them get back to sleep again could reduce the effect of osteoclasts on the bone.
3. This is the new ranking of the top 22 firms in drug research created by Sector & Sovereign Health. You’ll never guess who’s #1!